A whole-genome sequencing approach shows early promise over current commercial methods for identifying more patients likely ...
News Medical on MSN
Whole-genome Sequencing May Optimize PARP Inhibitor Use
A whole-genome sequencing approach shows early promise over current commercial methods for identifying more patients likely to benefit from PARP ...
Rice University researchers created CLASSIC, a platform that builds vast libraries of genetic circuits and links each full ...
Picture CRISPR-Cas9, a gene editing technology, as a GPS-guided scalpel: gRNA directs the Cas9 enzyme, a protein that cuts ...
As genetic engineering technologies such as clustered regularly interspaced short palindromic repeats (CRISPR) improve and ...
Researchers at Mount Sinai launch a new AI platform to match more cancer patients with clinical trials, aiming to expand ...
Sometimes, in genetics, two wrongs do make a right. A research team has recently shown that two harmful genetic variants, ...
Two Georgetown University Medical Center oncology professors published a new method for treating a lethal brain tumor in a ...
A new consensus document developed by The Blood Profiling Atlas in Cancer (BLOODPAC) Consortium was published in JCO ...
AI across the pharmaceutical ecosystem. The Illumina Billion Cell Atlas is the first tranche of its program to build a 5 billion cell atlas over three years, and will be the most comprehensive map of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results